Fasting Glucose of 6.1 mmol/L as a Possible Optimal Target for Type 2 Diabetic Patients with Insulin Glargine: A Randomized Clinical Trial

To observe whether different insulin glargine titration algorithms based on fasting blood glucose (FBG) levels lead to different glycaemic variations (GVs) in type 2 diabetes (T2D) patients, a prospective, randomized, single-centre, comparative, three-arm parallel-group, open-label, treat-to-target,...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Lu, Li, Fengfei, Zhou, Yue, Sun, Rui, Gao, Gu, Zhang, Qing, Tang, Yajuan, Dai, Lu, Wu, Jindan, Ma, Jianhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8294995/
https://www.ncbi.nlm.nih.gov/pubmed/34337072
http://dx.doi.org/10.1155/2021/5524313

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8294995/
https://www.ncbi.nlm.nih.gov/pubmed/34337072
http://dx.doi.org/10.1155/2021/5524313

Ejemplares similares